Endocrinology

Top Story

Non-albuminuric CKD increases CV, all-cause mortality risk in adults with type 1 diabetes

August 31, 2015

Adults with type 1 diabetes and non-albuminuric chronic kidney disease have an increased risk for both cardiovascular events and all-cause death, but no increased risk for albuminuria or end-stage renal disease, according to research in Diabetes Care.

In an observational follow-up study of more than 3,800 Finnish patients with type 1 diabetes, researchers also found that non-albuminuric CKD was rarer than what is typically seen in patients with type 2 diabetes, and that the highest risk for CV events or renal disease was seen in patients with type 1 diabetes and albuminuria.

‘Healthy Happy Meal’ bills could reduce children’s fat, sodium, caloric intake In the Journals

‘Healthy Happy Meal’ bills could reduce children’s fat, sodium, caloric intake

August 31, 2015
A proposed NYC bill could reduce calories, sodium and calories from fat in children’s combination meals at fast food restaurant chains, according to recently…
In the Journals

Diabetes, depression predict poor survival, rehospitalization in patients with heart failure

August 31, 2015
Poorer survival and rehospitalization in patients with heart failure are associated with comorbid diabetes and depressive symptoms, according to recent study findings…
In the Journals

Readmission rates may skew hospital quality measurements

August 31, 2015
Readmission rates were an ineffective measure of a hospital’s quality because they did not take into account readmissions from different hospitals, resulting in a…

Victoza will not be expanded for type 1 diabetes use

August 30, 2015
Novo Nordisk does not intend to submit an application to expand the label of Victoza for use in type 1 diabetes, following phase 3a trial results that showed a…
More News Headlines »
CME
Obesity Consults

Obesity Consults: Volume 2, Number 5
Practical Guide to Medications Approved for Chronic Weight Management

This activity is supported by educational grants from Eisai, Inc. and Vivus, Inc.

Several pharmacologic options for the management of obesity have been approved by the US FDA, giving clinicians a range…
More »
Meeting News Coverage Video
VIDEO: Chef integrates food and medicine in promotion of cardiometabolic health

VIDEO: Chef integrates food and medicine in promotion of cardiometabolic health

August 10, 2015
NEW ORLEANS — Chef Leah Sarris, program director at the Goldring Center for Culinary Medicine at Tulane…
More »
CME
Assessing Cornerstones for Successful Weight Loss

Assessing Cornerstones for Successful Weight Loss: Building a Foundation that Really Works

This activity is supported by an educational grant from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc.

Obesity has increased dramatically in the past 2 decades and is now considered a health care epidemic in the United…
More »
Current Issues
View the Current Issues